Compare MLI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLI | ARWR |
|---|---|---|
| Founded | 1917 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 9.6B |
| IPO Year | N/A | 1993 |
| Metric | MLI | ARWR |
|---|---|---|
| Price | $112.37 | $64.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $63.70 |
| AVG Volume (30 Days) | 668.6K | ★ 3.4M |
| Earning Date | 02-03-2026 | 11-25-2025 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | ★ 29.94 | N/A |
| EPS | ★ 6.68 | N/A |
| Revenue | ★ $4,139,698,000.00 | $829,448,000.00 |
| Revenue This Year | $12.69 | N/A |
| Revenue Next Year | $7.94 | N/A |
| P/E Ratio | $17.02 | ★ N/A |
| Revenue Growth | 15.71 | ★ 23258.15 |
| 52 Week Low | $66.84 | $9.57 |
| 52 Week High | $115.28 | $72.36 |
| Indicator | MLI | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 57.66 | 62.85 |
| Support Level | $112.78 | $59.51 |
| Resistance Level | $115.28 | $72.36 |
| Average True Range (ATR) | 2.14 | 4.67 |
| MACD | 0.01 | -0.11 |
| Stochastic Oscillator | 53.66 | 59.17 |
Mueller Industries Inc makes copper, brass, aluminum, and plastic products. The company reports three business segments: piping systems, industrial metals, and climate. Piping systems, earning majority of the company's revenue, produces tubes, fittings, rods, valves, and other products and operates various firms world-wide. The industrial metals segment manufactures impacts and micro-gauge, brass rod and copper bar products, and brass value-added products. The climate segment produces items used to create temperature-control goods, including valves, twisted tubes, coaxial heat exchangers, and others. Numerous systems use the aforementioned products, including HVAC, water distribution, refrigeration, and automotive.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.